The teratogenicity of drugs for nausea and vomiting of pregnancy: Perceived versus true risk

Gideon Koren, Zina Levichek

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

Women and health care providers commonly overestimate the teratogenic risk of medications in pregnancy. With regard to nausea and vomiting of pregnancy, this leads to an underutilization of pharmacologic therapy. Pregnancy termination has even been elected in some circumstances when safe and effective alternatives for nausea have not been attempted. The misperception of teratogenic risk is partly the result of the way data on safety are presented. An awareness of this can lead to more balanced patient and physician educational materials. To facilitate rational use of medicinal and nonmedicinal therapy for nausea and vomiting of pregnancy, we have developed an algorithm based on a recent systematic review of safety and efficacy in management of the problem. The hierarchical use of medication is based on strength of evidence of fetal safety.

Original languageEnglish
Pages (from-to)S248-S252
JournalAmerican Journal of Obstetrics and Gynecology
Volume186
Issue number5
DOIs
StatePublished - 2002
Externally publishedYes

Keywords

  • Drugs
  • Misinformation
  • Nausea and vomiting of pregnancy
  • Pregnancy
  • Risk perception
  • Teratogenicity

Fingerprint

Dive into the research topics of 'The teratogenicity of drugs for nausea and vomiting of pregnancy: Perceived versus true risk'. Together they form a unique fingerprint.

Cite this